266 related articles for article (PubMed ID: 14523647)
1. The role of bisphosphonates in diseases of childhood.
Srivastava T; Alon US
Eur J Pediatr; 2003 Nov; 162(11):735-51. PubMed ID: 14523647
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates use in children.
Sebestyen JF; Srivastava T; Alon US
Clin Pediatr (Phila); 2012 Nov; 51(11):1011-24. PubMed ID: 22935217
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates: from grandparents to grandchildren.
Srivastava T; Alon US
Clin Pediatr (Phila); 1999 Dec; 38(12):687-702. PubMed ID: 10618761
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates: the first 40 years.
Russell RG
Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
[TBL] [Abstract][Full Text] [Related]
5. The use of bisphosphonates in pediatrics.
Baroncelli GI; Bertelloni S
Horm Res Paediatr; 2014; 82(5):290-302. PubMed ID: 25376487
[TBL] [Abstract][Full Text] [Related]
6. [The successful development of bisphosphonates in the therapy of osteoporosis].
Fassbender WJ; Stumpf UC; Kurth A
Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
[TBL] [Abstract][Full Text] [Related]
7. [Biphosphonates in children: present and future].
Kone Paut I; Gennari JM; Retornaz K; Jouve JL; Bollini G
Arch Pediatr; 2002 Aug; 9(8):836-42. PubMed ID: 12205795
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates in the treatment of metabolic bone diseases.
Rodan GA; Balena R
Ann Med; 1993 Aug; 25(4):373-8. PubMed ID: 8217103
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of the bisphosphonates.
Fleisch H
Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy.
Li B; Ling Chau JF; Wang X; Leong WF
J Cell Biochem; 2011 May; 112(5):1229-42. PubMed ID: 21465521
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates: mode of action and pharmacology.
Russell RG
Pediatrics; 2007 Mar; 119 Suppl 2():S150-62. PubMed ID: 17332236
[TBL] [Abstract][Full Text] [Related]
12. [Bisphosphonates, their mechanism of action and properties useful in the therapy of metabolic bone diseases].
Fojtík Z; Kandusová M
Vnitr Lek; 1997 Apr; 43(4):234-7. PubMed ID: 9601843
[TBL] [Abstract][Full Text] [Related]
13. [Bisphosphonates in pharmacotherapy of bone diseases].
Iur'ieva EA; Matkovskaia TA; Elagina IA; Stoliarov IuIu
Eksp Klin Farmakol; 2000; 63(3):74-9. PubMed ID: 10934603
[TBL] [Abstract][Full Text] [Related]
14. Use of bisphosphonate therapy for osteoporosis in childhood and adolescence.
Batch JA; Couper JJ; Rodda C; Cowell CT; Zacharin M
J Paediatr Child Health; 2003 Mar; 39(2):88-92. PubMed ID: 12603794
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis.
Brumsen C; Hamdy NA; Papapoulos SE
Medicine (Baltimore); 1997 Jul; 76(4):266-83. PubMed ID: 9279333
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of bisphosphonates.
Cremers S; Drake MT; Ebetino FH; Bilezikian JP; Russell RGG
Br J Clin Pharmacol; 2019 Jun; 85(6):1052-1062. PubMed ID: 30650219
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update.
Fleisch H
Horm Metab Res; 1997 Mar; 29(3):145-50. PubMed ID: 9137986
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of bisphosphonates.
Devogelaer JP
Curr Opin Rheumatol; 1996 Jul; 8(4):384-91. PubMed ID: 8864593
[TBL] [Abstract][Full Text] [Related]
19. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis.
Kim MJ; Kim SN; Lee IS; Chung S; Lee J; Yang Y; Lee I; Koh SE
J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1343-50. PubMed ID: 26214607
[TBL] [Abstract][Full Text] [Related]
20. [Effects of bisphosphonates in arthroplasty].
Brankamp J; Eberhardt C; Landgräber S; von Knoch M; Saxler G; Löer F; Kurth AA
Z Orthop Ihre Grenzgeb; 2006; 144(2):187-91. PubMed ID: 16625449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
